AG
TMO icon

Ascent Group’s Thermo Fisher Scientific TMO Stock Holding History

Ascent Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.52M Sell
11,221
-355
-3% -$193K 0.19% 114
2025
Q4 		$6.71M Buy
11,576
+613
+6% +$347K 0.23% 93
2025
Q3 		$5.32M Buy
10,963
+3,119
+40% +$1.45M 0.19% 114
2025
Q2 		$3.18M Sell
7,844
-1,007
-11% -$421K 0.12% 162
2025
Q1 		$4.4M Buy
8,851
+1,454
+20% +$787K 0.19% 117
2024
Q4 		$3.85M Sell
7,397
-699
-9% -$384K 0.29% 88
2024
Q3 		$5.01M Sell
8,096
-2,933
-27% -$1.74M 0.38% 57
2024
Q2 		$6.1M Buy
11,029
+561
+5% +$321K 0.5% 41
2024
Q1 		$6.08M Buy
10,468
+3,484
+50% +$1.96M 0.54% 33
2023
Q4 		$3.82M Buy
6,984
+24
+0.3% +$11.6K 0.36% 61
2023
Q3 		$3.09M Sell
6,960
-111
-2% -$59.1K 0.34% 69
2023
Q2 		$3.93M Sell
7,071
-779
-10% -$420K 0.43% 53
2023
Q1 		$4.52M Sell
7,850
-876
-10% -$494K 0.48% 41
2022
Q4 		$4.81M Buy
8,726
+530
+6% +$281K 0.57% 33
2022
Q3 		$4.21M Buy
8,196
+115
+1% +$64.4K 0.51% 43
2022
Q2 		$4.84M Buy
8,081
+431
+6% +$237K 0.58% 32
2022
Q1 		$4.52M Sell
7,650
-23
-0.3% -$13.2K 0.53% 42
2021
Q4 		$4.45M Buy
+7,673
New +$4.79M 0.57% 36

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ascent Group's TMO Position: Q1 2026 in Review

Ascent Group reduced its Thermo Fisher Scientific (TMO) stake by 3.1% in Q1 2026, selling an estimated $193K and leaving 11,221 shares worth $5.52M. The position accounts for 0.19% of the portfolio, ranked #114.

Ascent Group first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $6.71M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Ascent Group held 11,221 shares of Thermo Fisher Scientific worth $5.52M as of Q1 2026.
  • Ascent Group sold 355 Thermo Fisher Scientific shares in Q1 2026, an estimated $193K.
  • Thermo Fisher Scientific made up 0.19% of Ascent Group's portfolio in Q1 2026, its #114 holding.
  • Ascent Group first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
  • Ascent Group's Thermo Fisher Scientific position peaked at $6.71M in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.